Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Verena Vöhringer is active.

Publication


Featured researches published by Verena Vöhringer.


ChemMedChem | 2018

Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor

Marie-Pierre Collin; Mario Lobell; Walter Dr. Hübsch; Dirk Brohm; Hartmut Schirok; Rolf Jautelat; Klemens Lustig; Ulf Bömer; Verena Vöhringer; Mélanie Héroult; Sylvia Grünewald; Holger Hess-Stumpp

Rogaratinib (BAY 1163877) is a highly potent and selective small‐molecule pan‐fibroblast growth factor receptor (FGFR) inhibitor (FGFR1–4) for oral application currently being investigated in phase 1 clinical trials for the treatment of cancer. In this publication, we report its discovery by de novo structure‐based design and medicinal chemistry optimization together with its pharmacokinetic profile.


Archive | 1998

Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases

Joachim Mittendorf; Jürgen Dr. Dressel; Michael Matzke; Jörg Keldenich; Klaus-Helmut Mohrs; Siegfried Raddatz; Jürgen Franz; Peter Spreyer; Verena Vöhringer; Joachim Schuhmacher; Michael-Harold Rock; Ervin Horvath; Arno Friedl; Frank Mauler; Jean De Vry; Reinhard Jork


Archive | 2001

Use of known agonists of the central cannabinoid receptor CB1

Joachim Mittendorf; Jürgen Dr. Dressel; Michael Matzke; Jürgen Franz; Peter Spreyer; Verena Vöhringer; Joachim Schuhmacher; Arno Friedl; Ervin Horvath; Frank Mauler; Jean-Marie-Viktor De Vry; Reinhard Jork


Archive | 1999

Aryl sulphonamides and analogues

Joachim Mittendorf; Jürgen Dr. Dressel; Michael Matzke; Jörg Keldenich; Frank Mauler; Jean-Marie-Victor de Vry; Jürgen Franz; Peter Spreyer; Verena Vöhringer; Joachim Schumacher; Michael-Harold Rock; Ervin Horvath; Arno Friedl; Klaus-Helmut Mohrs; Siegfried Raddatz; Reinhard Jork


Archive | 2001

Indole derivatives as ligands of thyroid receptors

Helmut Haning; Michael Woltering; Gunter Schmidt; Hilmar Bischoff; Axel Kretschmer; Verena Vöhringer; Christiane Faeste


Archive | 1999

Aryl sulphonamide amino acid esters and analogues

Joachim Mittendorf; Jürgen Dr. Dressel; Michael Matzke; Jörg Keldenich; Frank Mauler; Jean-Marie-Viktor De Vry; Jürgen Franz; Peter Spreyer; Verena Vöhringer; Joachim Schumacher; Michael-Harold Rock; Ervin Horvath; Arno Friedl


Archive | 2001

INDOLES FOR TREATING DISEASES THAT CAN BE TREATED USING THYROID HORMONES

Helmut Haning; Gunter Schmidt; Josef Pernerstorfer; Carsten Schmeck; Ulrich Dr. Müller; Hilmar Bischoff; Verena Vöhringer; Peter Reinemer; Heiner Apeler; Delf Schmidt; Willi Jonghaus; Christiane Faeste; Martin Zoche; Markus Hauswald; Michael Woltering; Axel Kretschmer


Archive | 2001

Amino-and amido-diphenyl ethers

Helmut Haning; Josef Pernerstorfer; Gunter Schmidt; Michael Woltering; Hilmar Bischoff; Verena Vöhringer; Axel Kretschmer; Christiane Faeste


Archive | 2005

Cyanoguanidine-substituted pyrazolines

Swen Allerheiligen; Dirk Brohm; Nicole Diedrichs; Walter Dr. Hübsch; Britta-Nicole Fröhlen; Christoph Gerdes; Mark Jean Gnoth; Elisabeth Perzborn; Verena Vöhringer


Archive | 2001

Indazoles having an action similar to that of a thyroid hormone, method for the production thereof, and their use in medicaments

Michael Woltering; Helmut Haning; Gunter Schmidt; Josef Pernerstorfer; Hilmar Bischoff; Axel Kretschmer; Verena Vöhringer; Christiane Faeste

Researchain Logo
Decentralizing Knowledge